A Novel Partially Covered Self-Expandable Metallic Stent with Proximal Flare in Patients with Malignant Gastric Outlet Obstruction
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Endoscopic placement of self-expandable metal stents (SEMSs) has emerged as a palliative treatment for malignant gastric outlet obstruction (GOO). Although covered SEMSs can prevent tumor ingrowth, frequent migration of covered SEMSs may offset their advantages in preventing tumor ingrowth. Methods: We conducted this multicenter, single-arm, retrospective study at six tertiary referral centers to evaluate the safety and efficacy of a partially covered SEMS with an uncovered large-bore flare at the proximal end as an antimigration system in 41 patients with symptomatic malignant GOO. The primary outcome was clinical success, and the secondary outcomes were technical success, stent dysfunction, adverse events, and survival after stent placement. Results: The technical and clinical success rates were 100% and 95%, respectively. Stent dysfunctions occurred in 17 patients (41%), including stent migration in nine (23%), tumor ingrowth in one (2%), and tumor overgrowth in four (10%). Two patients (5%) developed adverse events: one pancreatitis and one perforation. No procedurerelated death was observed. Conclusions: A novel partially covered SEMS with a large-bore flare proximal end was safe and effective for malignant GOO but failed to prevent stent migration. Further research is warranted to develop a covered SEMS with an optimal antimigration system.
Abstract
Background/Aims: Endoscopic placement of self-expandable metal stents (SEMSs) has emerged as a palliative treatment for malignant gastric outlet obstruction (GOO). Although covered SEMSs can prevent tumor ingrowth, frequent migration of covered SEMSs may offset their advantages in preventing tumor ingrowth. Methods: We conducted this multicenter, single-arm, retrospective study at six tertiary referral centers to evaluate the safety and efficacy of a partially covered SEMS with an uncovered large-bore flare at the proximal end as an antimigration system in 41 patients with symptomatic malignant GOO. The primary outcome was clinical success, and the secondary outcomes were technical success, stent dysfunction, adverse events, and survival after stent placement. Results: The technical and clinical success rates were 100% and 95%, respectively. Stent dysfunctions occurred in 17 patients (41%), including stent migration in nine (23%), tumor ingrowth in one (2%), and tumor overgrowth in four (10%). Two patients (5%) developed adverse events: one pancreatitis and one perforation. No procedurerelated death was observed. Conclusions: A novel partially covered SEMS with a large-bore flare proximal end was safe and effective for malignant GOO but failed to prevent stent migration. Further research is warranted to develop a covered SEMS with an optimal antimigration system.
참고문헌 (27)
- Jeurnink SM, "Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial", Gastrointest Endosc, 71, pp.490~499 (2010)
- Chandrasegaram MD, "Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction", Surg Endosc, 26, pp.323~329 (2012)
- Khashab M, "Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction", Surg Endosc, 27, pp.2068~2075 (2013)
- Zheng B, "Endoscopic stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction", Dig Endosc, 24, pp.71~78 (2012)
- Maetani I, "Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study", Gastrointest Endosc, 66, pp.355~360 (2007)
- Sasaki T, "Japanese multicenter estimation of WallFlex duodenal stent for unresectable malignant gastric outlet obstruction", Dig Endosc, 25, pp.1~6 (2013)
- van den Berg MW, "First data on the Evolution duodenal stent for palliation of malignant gastric outlet obstruction (DUOLUTION study): a prospective multicenter study", Endoscopy, 45, pp.174~181 (2013)
- van Hooft JE, "Safety and efficacy of a new non-foreshortening nitinol stent in malignant gastric outlet obstruction (DUONITI study): a prospective, multicenter study", Endoscopy, 43, pp.671~675 (2011)
- Kim CG, "Covered versus uncovered selfexpandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study", Gastrointest Endosc, 72, pp.25~32 (2010)
- Lee KM, "Palliative treatment of malignant gastroduodenal obstruction with metallic stent: prospective comparison of covered and uncovered stents", Scand J Gastroenterol, 44, pp.846~852 (2009)
- Maetani I, "Placement of a triplelayered covered versus uncovered metallic stent for palliation of malignant gastric outlet obstruction: a multicenter randomized trial", Dig Endosc, 26, pp.192~199 (2014)
- Isayama H, "Management of malignant gastric outlet obstruction with a modified triple-layer covered metal stent", Gastrointest Endosc, 75, pp.757~763 (2012)
- Isayama H, "Measurement of radial and axial forces of biliary self-expandable metallic stents", Gastrointest Endosc, 70, pp.37~44 (2009)
- Piesman M, "Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial", Am J Gastroenterol, 104, pp.2404~2411 (2009)
- Mutignani M, "Combined endoscopic stent insertion in malignant biliary and duodenal obstruction", Endoscopy, 39, pp.440~447 (2007)
- Cotton PB, "A lexicon for endoscopic adverse events: report of an ASGE workshop", Gastrointest Endosc, 71, pp.446~454 (2010)
- Nakai Y, "A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer", Cancer Chemother Pharmacol, 74, pp.911~915 (2014)
- Takahara N, "Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis", J Gastrointest Cancer, 45, pp.307~311 (2014)
- Ishigami H, "Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis", Ann Oncol, 21, pp.67~70 (2010)
- Lim SG, "Conformable covered versus uncovered self-expandable metallic stents for palliation of malignant gastroduodenal obstruction: a randomized prospective study", Dig Liver Dis, 46, pp.603~608 (2014)
- Kim JH, "Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients", Gastrointest Endosc, 66, pp.256~264 (2007)
- Juliana Yang, "Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience", Surgical Endoscopy, 31(3), pp.1414~1419 (2017), Springer Nature[DOI]
- Diana M, "Esophageal covered stent fixation using an endoscopic over-the-scope clip: mechanical proof of the concept and first clinical experience", Surg Endosc, 29, pp.3367~3372 (2015)
- Kim SY, "Bridging across the ampulla of Vater with covered self-expanding metallic stents: is it contraindicated when treating malignant gastroduodenal obstruction", J Vasc Interv Radiol, 19, pp.1607~1613 (2008)
- Hamada T, "Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer", Gastrointest Endosc, 74, pp.548~555 (2011)
- Hamada T, "Transmural biliary drainage can be an alternative to transpapillary drainage in patients with an indwelling duodenal stent", Dig Dis Sci, 59, pp.1931~1938 (2014)
- Park DH, "Endoscopic ultrasonography-guided hepaticogastrostomy", Gastrointest Endosc Clin N Am, 22, pp.271~280 (2012)